{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:16:38Z","timestamp":1741065398033,"version":"3.38.0"},"reference-count":35,"publisher":"EDP Sciences","issue":"8-9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1051\/medsci\/2010268-9734","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T08:29:32Z","timestamp":1299140972000},"page":"734-739","source":"Crossref","is-referenced-by-count":2,"title":["S\u00e9lectivit\u00e9 fonctionnelle des ligands des r\u00e9cepteurs opiac\u00e9s"],"prefix":"10.1051","volume":"26","author":[{"given":"Nicolas","family":"Audet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9lodie","family":"Archer-Lahlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lissa","family":"Richard-Lalonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Pineyro-Filpo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2010,8,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Urban JD, Clarke WP, von Zastrow M,et al. Functional selectivity and classical concepts of quantitative pharmacology.J Pharmacol Exp Ther2007 ; 320 : 1-13.","DOI":"10.1124\/jpet.106.104463"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Audet N, Paquin-Gobeil M, Landry-Paquet O,et al. Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands.J Biol Chem2005 ; 280 : 7808-16.","DOI":"10.1074\/jbc.M411695200"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Kenakin T. Functional selectivity through protean and biased agonism: who steers the ship?Mol Pharmacol2007 ; 72 : 1393-401.","DOI":"10.1124\/mol.107.040352"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"May LT, Hill SJ. ERK phosphorylation: spatial and temporal regulation by G protein-coupled receptors.Int J Biochem Cell Biol2008 ; 40 : 2013-7.","DOI":"10.1016\/j.biocel.2008.04.001"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Mathews JL, Smrcka AV, Bidlack JM. A novel G-betagamma-subunit inhibitor selectively modulates mu-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence.J Neurosci2008 ; 28 : 12183-9.","DOI":"10.1523\/JNEUROSCI.2326-08.2008"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"McDowell TS. Fentanyl decreases Ca2+ currents in a population of capsaicin-responsive sensory neurons.Anesthesiology2003 ; 98 : 223-31.","DOI":"10.1097\/00000542-200301000-00034"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Marker CL, Lujan R, Loh HH, Wickman K. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.J Neurosci2005 ; 25 : 3551-9.","DOI":"10.1523\/JNEUROSCI.4899-04.2005"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Zheng H, Loh HH, Law Py. Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERK) Translocate to Nucleus in Contrast to G protein-dependent ERK activation.Mol Pharmacol2008 ; 73 : 178-90.","DOI":"10.1124\/mol.107.039842"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Kieffer BL, Gaveriaux-Ruff C. Exploring the opioid system by gene knockout.Prog Neurobiol2002 ; 66 : 285-306.","DOI":"10.1016\/S0301-0082(02)00008-4"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Negus SS, Schrode K, Stevenson GW. Micro\/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability.Exp Clin Psychopharmacol2008 ; 16 : 386-99.","DOI":"10.1037\/a0013088"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Beaudry H, Proteau-Gagn\u00e9 A, Li S,et al. Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.Neuroscience2009 ; 161 : 381-91.","DOI":"10.1016\/j.neuroscience.2009.03.053"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Walsh SL, Strain EC, Abreu ME, Bigelow GE. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.Psychopharmacology (Berl)2001 ; 157 : 151-62.","DOI":"10.1007\/s002130100788"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"McLaughlin JP, Myers LC, Zarek PE,et al. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.J Biol Chem2004 ; 279 : 1810-8.","DOI":"10.1074\/jbc.M305796200"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Bruchas MR, Land BB, Aita M,et al. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.J Neurosci2007 ; 27 : 11614-23.","DOI":"10.1523\/JNEUROSCI.3769-07.2007"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"May CN, Dashwood MR, Whitehead CJ, Mathias CJ. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution.Br J Pharmacol1989 ; 98 : 903-13.","DOI":"10.1111\/j.1476-5381.1989.tb14620.x"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Porreca F, Mosberg HI, Hurst R,et al. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.J Pharmacol Exp Ther1984 ; 230 : 341-8.","DOI":"10.1016\/S0022-3565(25)21481-1"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Cowan A, Zhu XZ, Mosberg HI,et al. Direct dependence studies in rats with agents selective for different types of opioid receptor.J Pharmacol Exp Ther1988 ; 246 : 950-5.","DOI":"10.1016\/S0022-3565(25)22201-7"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Broom DC, Nitsche JF, Pintar JE,et al. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.J Pharmacol Exp Ther2002 ; 303 : 723-9.","DOI":"10.1124\/jpet.102.036525"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Pradhan AA, Becker JA, Scherrer G,et al. In vivodelta opioid receptor internalization controls behavioral effects of agonists.PLoS One2009 ; 4 : e5425.","DOI":"10.1371\/journal.pone.0005425"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Alves ID, Ciano KA, Boguslavski V,et al. Selectivity, cooperativity, and reciprocity in the interactions between the delta-opioid receptor, its ligands, and G-proteins.J Biol Chem2004 ; 279 : 44673-82.","DOI":"10.1074\/jbc.M404713200"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Audet N, Gales C, Archer-Lahlou E,et al. Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing deltaopioid receptors and heterotrimeric G proteins.J Biol Chem2008 ; 283 : 15078-88.","DOI":"10.1074\/jbc.M707941200"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Allouche S, Polastron J, Hasbi A,et al. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.Biochem J1999 ; 342 : 71-8.","DOI":"10.1042\/bj3420071"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Stanasila L, Lim WK, Neubig RR, Pattus F. Coupling efficacy and selectivity of the human muopioid receptor expressed as receptor-Galpha fusion proteins inEscherichia coli. J Neurochem2000 ; 75 : 1190-9.","DOI":"10.1046\/j.1471-4159.2000.0751190.x"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Gupta A, Decaillot FM, Devi LA. Targeting opioid receptor heterodimers: strategies for screening and drug development.AAPS J2006 ; 8 : E153-9.","DOI":"10.1208\/aapsj080118"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Fan T, Varghese G, Nguyen T,et al. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers.J Biol Chem2005 ; 280 : 38478-88.","DOI":"10.1074\/jbc.M505644200"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Johnson EA, Oldfield S, Braksator E,et al. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.Mol Pharmacol2006 ; 70 : 676-85.","DOI":"10.1124\/mol.106.022376"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Gabra BH, Bailey CP, Kelly E,et al. Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice.Brain Res2008 ; 1217 : 70-7.","DOI":"10.1016\/j.brainres.2008.04.036"},{"key":"R28","unstructured":"Pineyro G. Fonctional selectivity at opioid receptors. In : Neve KA, ed.Fonctional selectivity of G protein-coupled receptor ligands. New york : Humana Press, 2009 : 243-66."},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Groer CE, Tidgewell K, Moyer RA,et al. An opioid agonist that does not induce micro-opioid receptor: arrestin interactions or receptor internalization.Mol Pharmacol2007 ; 71 : 549-57.","DOI":"10.1124\/mol.106.028258"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Okura T, Varga EV, Hosohata y,et al. Agonist-specific down-regulation of the human delta-opioid receptor.Eur J Pharmacol2003 ; 459 : 9-16.","DOI":"10.1016\/S0014-2999(02)02823-6"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Archer-Lahlou E, Audet N, Amraei MG,et al. Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling.J Cell Mol Med2009 ; 13 : 147-63.","DOI":"10.1111\/j.1582-4934.2008.00308.x"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Ho IK, Loh HH, Way EL. Effects of cyclic 3\u2019, 5\u2019-adenosine monophosphate on morphine tolerance and physical dependence.J Pharmacol Exp Ther1973 ; 185 : 347-57.","DOI":"10.1016\/S0022-3565(25)29514-3"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Bernstein MA, Welch SP. Effects of spinalversussupraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice.Drug Alcohol Depend1997 ; 44 : 41-6.","DOI":"10.1016\/S0376-8716(96)01320-8"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"yoshimura M, Wu PH, Hoffman PL, Tabakoff B. Overexpression of type 7 adenylyl cyclase in the mouse brain enhances acute and chronic actions of morphine.Mol Pharmacol2000 ; 58 : 1011-6.","DOI":"10.1124\/mol.58.5.1011"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Li S, Lee ML, Bruchas MR,et al. Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses.Mol Pharmacol2006 ; 70 : 1742-9.","DOI":"10.1124\/mol.106.025783"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2010268-9734\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T04:56:00Z","timestamp":1740977760000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2010268-9734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":35,"journal-issue":{"issue":"8-9"},"alternative-id":["medsci2010268-9p734"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2010268-9734","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"type":"print","value":"0767-0974"},{"type":"electronic","value":"1958-5381"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}